Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Artemis Therapeutics, Inc. (INKS.OB) since 2017 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Artemis Therapeutics, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1062128.
Total stock buying since 2017: $0.
Total stock sales since 2017: $47.
Total stock option exercises since 2017: $352.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2018 | 0 | $0 | 182 | $47 | 0 | $0 |
| 2017 | 25,000 | $0 | 0 | $0 | 35,202 | $352 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2018-12 | 0 | $0 | 182 | $47 | 0 | $0 |
| 2017-10 | 25,000 | $0 | 0 | $0 | 0 | $0 |
| 2017-06 | 0 | $0 | 0 | $0 | 35,202 | $352 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2018-12-18 | Peleg Gadi | Sale | 182 | .26 | 47 |
| 2017-10-23 | Culley Brian M (Chief Executive Officer) | Buy | 25,000 | .00 | 0 |
| 2017-06-26 | Wolf Dana (Chief Scientific Officer) | Option Ex | 35,202 | .01 | 352 |
Insider trading activities including stock purchases, stock sales, and option exercises of INKS.OB listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Artemis Therapeutics, Inc. (symbol INKS.OB, CIK number 1062128) see the Securities and Exchange Commission (SEC) website.